<code id='79CAC67C63'></code><style id='79CAC67C63'></style>
    • <acronym id='79CAC67C63'></acronym>
      <center id='79CAC67C63'><center id='79CAC67C63'><tfoot id='79CAC67C63'></tfoot></center><abbr id='79CAC67C63'><dir id='79CAC67C63'><tfoot id='79CAC67C63'></tfoot><noframes id='79CAC67C63'>

    • <optgroup id='79CAC67C63'><strike id='79CAC67C63'><sup id='79CAC67C63'></sup></strike><code id='79CAC67C63'></code></optgroup>
        1. <b id='79CAC67C63'><label id='79CAC67C63'><select id='79CAC67C63'><dt id='79CAC67C63'><span id='79CAC67C63'></span></dt></select></label></b><u id='79CAC67C63'></u>
          <i id='79CAC67C63'><strike id='79CAC67C63'><tt id='79CAC67C63'><pre id='79CAC67C63'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:fashion    Page View:6579
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In